COMMUNIQUÉS West-GlobeNewswire

-
Jabez Biosciences, Inc. Opens Second Clinical Site in Phase 1 Oncology Clinical Study of JBZ-001
15/08/2025 -
Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships
15/08/2025 -
BioSig Technologies, Inc. & Streamex Announce Closing of $15 Million Public Offering
15/08/2025 -
Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH
15/08/2025 -
rYojbaba Co., Ltd. Announces Closing of $5 Million Initial Public Offering of Japanese Common Shares
15/08/2025 -
Bioxytran Unveils Revolutionary Precision Diagnostics on Tissue Oxygenation
15/08/2025 -
Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational Efficiencies
15/08/2025 -
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15/08/2025 -
Sienna Announces August Dividend
15/08/2025 -
Regen BioPharma Discusses Potential Impact of HemaXellerate on Chemotherapy Treament Market
15/08/2025 -
Cingulate Provides Management Team Update
15/08/2025 -
Autonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
15/08/2025 -
AIM ImmunoTech Reports Second Quarter 2025 Financial Results and Provides Corporate Update
15/08/2025 -
HeartSciences Announces Conference Participation and Investor Webinar
15/08/2025 -
BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor
15/08/2025 -
La Croix-Rouge met sur pied un fonds de secours en réponse aux feux de forêt à Terre-Neuve
15/08/2025 -
Appeal launched to support people impacted by Newfoundland fires
15/08/2025 -
Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
15/08/2025 -
Plus Therapeutics Reports Stockholders’ Equity in Excess of $2.5 million in Compliance with Nasdaq Equity Requirements
15/08/2025
Pages